Bowyer EdD / Bowyer / Cahill MAEA | Pediatric Occupational Therapy Handbook | E-Book | sack.de
E-Book

E-Book, Englisch, 417 Seiten

Bowyer EdD / Bowyer / Cahill MAEA Pediatric Occupational Therapy Handbook

A Guide to Diagnoses and Evidence-Based Interventions
1. Auflage 2008
ISBN: 978-0-323-07100-0
Verlag: Elsevier HealthScience EN
Format: EPUB
 Kopierschutz: 6 - ePub Watermark

A Guide to Diagnoses and Evidence-Based Interventions

E-Book, Englisch, 417 Seiten

ISBN: 978-0-323-07100-0
Verlag: Elsevier HealthScience EN
Format: EPUB
 Kopierschutz: 6 - ePub Watermark

Combining essential assessment guidance with the latest evidence-based intervention strategies, this compact reference helps you quickly locate the information you need to evaluate and manage pediatric disorders. Access diagnosis-specific information on epidemiology, precautions, and more, as well as suggested interventions supported by the latest research, all in a convenient, pocket-sized handbook perfect for the busy clinical setting. Information is presented in a consistent format for easy reference and complies with the OT Practice Framework to help you ensure the most effective therapeutic outcomes.
  • Evidence-based evaluation and intervention content on over 80 common pediatric diagnoses helps you make sound clinical decisions supported by documented research.
  • Intervention strategies are highlighted through the text for fast, easy reference when planning treatment.
  • Convenient A-Z organization and pocket-sized format help you locate diagnosis-specific information quickly in busy practice settings.
  • Case studies illustrate real-life patient scenarios and help hone your clinical reasoning skills.
Bowyer EdD / Bowyer / Cahill MAEA Pediatric Occupational Therapy Handbook jetzt bestellen!

Autoren/Hrsg.

Bowyer EdD, Otr/L
Bowyer, Patricia
Cahill MAEA, Otr/L

Weitere Infos & Material

1;Front cover;1
2;Pediatric Occupational Therapy Handbook;4
3;Copyright page;5
4;Preface;8
5;Table of contents;10
6;Section I: Guide to Pediatric Practice;14
6.1;Chapter 1: Using the Occupational Therapy Practice Framework in Pediatric Practice;16
6.1.1;Creation of a Unified Language;16
6.1.2;Occupational Therapy Practice Framework;17
6.1.3;REFERENCES;21
6.2;Chapter 2: Using Evidence to Guide Occupational Therapy Practice;22
6.2.1;Step 1: Form the Question;22
6.2.2;Step 2: Uncover the Best Evidence;23
6.2.3;Step 3: Evaluate the Information and Determine How It Can Be Applied in Your Practice;25
6.2.4;FURTHER READING;26
7;Section II: Guide to Diagnoses and Interventions;28
7.1;Chapter 3: Achondroplasia;30
7.1.1;Epidemiology;30
7.1.2;Impact on Performance Skills;30
7.1.3;Impact on Client Factors (Body Functions and Structures);30
7.1.4;Precautions;31
7.1.5;Evaluation;31
7.1.6;Suggested Assessment Tools;31
7.1.7;FURTHER READING;32
7.2;Chapter 4: Acquired Brain Injury;34
7.2.1;Epidemiology;34
7.2.2;Impact on Performance Skills;34
7.2.3;Impact on Client Factors (Body Functions and Structures);35
7.2.4;Precautions;35
7.2.5;Evaluation;35
7.2.6;Suggested Assessment Tools;35
7.2.7;FURTHER READING;37
7.3;Chapter 5: Acquired Immunodeficiency Syndrome;38
7.3.1;Epidemiology;38
7.3.2;Impact on Performance Skills;38
7.3.3;Impact on Client Factors (Body Functions and Structures);38
7.3.4;Precautions;39
7.3.5;Evaluation;39
7.3.6;Suggested Assessment Tools;39
7.3.7;FURTHER READING;40
7.4;Chapter 6: Albers-Schönberg Disease;42
7.4.1;Epidemiology;42
7.4.2;Impact on Performance Skills;42
7.4.3;Impact on Client Factors (Body Functions and Structures);43
7.4.4;Precautions;43
7.4.5;Evaluation;43
7.4.6;Suggested Assessment Tools;43
7.4.7;FURTHER READING;44
7.5;Chapter 7: Amblyopia;46
7.5.1;Epidemiology;46
7.5.2;Impact on Performance Skills;46
7.5.3;Impact on Client Factors (Body Functions and Structures);47
7.5.4;Precautions;47
7.5.5;Evaluation;47
7.5.6;Suggested Assessment Tools;47
7.5.7;FURTHER READING;48
7.6;Chapter 8: Anemia;50
7.6.1;Epidemiology;50
7.6.2;Impact on Performance Skills;50
7.6.3;Impact on Client Factors (Body Functions and Structures);51
7.6.4;Precautions;51
7.6.5;Evaluation;51
7.6.6;Suggested Assessment Tools;51
7.6.7;FURTHER READING;52
7.7;Chapter 9: Angelman Syndrome;54
7.7.1;Epidemiology;54
7.7.2;Impact on Performance Skills;54
7.7.3;Impact on Client Factors (Body Functions and Structures);55
7.7.4;Precautions;55
7.7.5;Evaluation;55
7.7.6;Suggested Assessment Tools;55
7.7.7;FURTHER READING;57
7.8;Chapter 10: Anorexia;58
7.8.1;Epidemiology;58
7.8.2;Impact on Areas of Occupation;58
7.8.3;Impact on Performance Skills;58
7.8.4;Impact on Client Factors (Body Functions and Structures);59
7.8.5;Precautions;59
7.8.6;Evaluation;59
7.8.7;Suggested Assessment Tools;60
7.8.8;FURTHER READING;60
7.9;Chapter 11: Anxiety;62
7.9.1;Epidemiology;62
7.9.2;Impact on Performance Skills;62
7.9.3;Impact on Client Factors (Body Functions and Structures);63
7.9.4;Precautions;63
7.9.5;Evaluation;63
7.9.6;Suggested Assessment Tools;63
7.9.7;FURTHER READING;64
7.10;Chapter 12: Apnea;66
7.10.1;Epidemiology;66
7.10.2;Impact on Performance Skills;67
7.10.3;Impact on Client Factors (Body Functions and Structures);67
7.10.4;Precautions;67
7.10.5;Evaluation;67
7.10.6;Suggested Assessment Tools;67
7.10.7;FURTHER READING;68
7.11;Chapter 13: Arthrogryposis Multiplex Congenita;70
7.11.1;Epidemiology;70
7.11.2;Impact on Areas of Occupation;70
7.11.3;Impact on Performance Skills;71
7.11.4;Impact on Client Factors (Body Functions and Structures);72
7.11.5;Precautions;72
7.11.6;Evaluation;72
7.11.7;Suggested Assessment Tools;72
7.11.8;FURTHER READING;74
7.12;Chapter 14: Asthma;76
7.12.1;Epidemiology;76
7.12.2;Impact on Performance Patterns;76
7.12.3;Impact on Performance Skills;76
7.12.4;Impact on Client Factors (Body Functions and Structures);77
7.12.5;Precautions;77
7.12.6;Evaluation;77
7.12.7;Suggested Assessment Tools;77
7.12.8;FURTHER READING;78
7.13;Chapter 15: Attention Deficit/Hyperactivity Disorder;80
7.13.1;Epidemiology;80
7.13.2;Impact on Performance Skills;81
7.13.3;Impact on Client Factors (Body Functions and Structures);82
7.13.4;Precautions;82
7.13.5;Evaluation;82
7.13.6;Suggested Assessment Tools;82
7.13.7;FURTHER READING;84
7.14;Chapter 16: Autism Spectrum Disorders;86
7.14.1;Epidemiology;86
7.14.2;Impact on Areas of Occupation;89
7.14.3;Impact on Performance Patterns;89
7.14.4;Impact on Performance Skills;89
7.14.5;Impact on Client Factors (Body Functions and Structures);90
7.14.6;Precautions;90
7.14.7;Evaluation;90
7.14.8;Suggested Assessment Tools;90
7.14.9;FURTHER READING;92
7.15;Chapter 17: Bipolar Disorder;94
7.15.1;Epidemiology;94
7.15.2;Impact on Performance Skills;94
7.15.3;Impact on Client Factors (Body Functions and Structures);95
7.15.4;Precautions;96
7.15.5;Evaluation;96
7.15.6;Suggested Assessment Tools;96
7.15.7;FURTHER READING;97
7.16;Chapter 18: Brachial Plexus Injury;98
7.16.1;Epidemiology;98
7.16.2;Impact on Performance Skills;98
7.16.3;Impact on Client Factors (Body Functions and Structures);99
7.16.4;Precautions;99
7.16.5;Evaluation;100
7.16.6;Suggested Assessment Tools;100
7.16.7;FURTHER READING;101
7.17;Chapter 19: Bronchopulmonary Dysplasia;102
7.17.1;Epidemiology;102
7.17.2;Impact on Occupational Performance;102
7.17.3;Impact on Performance Patterns;102
7.17.4;Impact on Client Factors (Body Functions and Structures);103
7.17.5;Precautions;103
7.17.6;Evaluation;103
7.17.7;FURTHER READING;104
7.18;Chapter 20: Bulimia;106
7.18.1;Epidemiology;106
7.18.2;Impact on Areas of Occupation;106
7.18.3;Impact on Performance Skills;106
7.18.4;Impact on Client Factors (Body Functions and Structures);107
7.18.5;Precautions;107
7.18.6;Evaluation;107
7.18.7;Suggested Assessment Tools;107
7.18.8;FURTHER READING;108
7.19;Chapter 21: Cerebral Palsy;110
7.19.1;Epidemiology;110
7.19.2;Impact on Performance Skills;111
7.19.3;Impact on Client Factors (Body Functions and Structures);112
7.19.4;Precautions;118
7.19.5;Evaluation;118
7.19.6;Suggested Assessment Tools;118
7.19.7;FURTHER READING;119
7.20;Chapter 22: Cleft Palate;120
7.20.1;Epidemiology;120
7.20.2;Impact on Occupational Participation;120
7.20.3;Impact on Performance Skills;120
7.20.4;Impact on Client Factors (Body Functions and Structures);120
7.20.5;Precautions;121
7.20.6;Evaluation;121
7.20.7;FURTHER READING;122
7.21;Chapter 23: Conduct Disorder;124
7.21.1;Epidemiology;124
7.21.2;Impact on Occupational Performance;124
7.21.3;Impact on Performance Patterns;125
7.21.4;Impact on Performance Skills;125
7.21.5;Impact on Client Factors (Body Functions and Structures);125
7.21.6;Precautions;125
7.21.7;Evaluation;125
7.21.8;Suggested Assessment Tools;125
7.21.9;FURTHER READING;127
7.22;Chapter 24: Congenital Clubfoot ( Talipes Equinovarus );128
7.22.1;Epidemiology;128
7.22.2;Impact on Performance Skills;128
7.22.3;Impact on Client Factors (Body Functions and Structures);129
7.22.4;Precautions;129
7.22.5;Evaluation;129
7.22.6;Suggested Assessment Tools;129
7.22.7;FURTHER READING;130
7.23;Chapter 25: Congenital Heart Defects;132
7.23.1;Epidemiology;132
7.23.2;Impact on Occupational Performance;133
7.23.3;Impact on Performance Patterns;134
7.23.4;Impact on Performance Skills;134
7.23.5;Impact on Client Factors (Body Functions and Structures);134
7.23.6;Precautions;134
7.23.7;Evaluation;134
7.23.8;Suggested Assessment Tools;134
7.23.9;FURTHER READING;135
7.24;Chapter 26: Congenital Obstructive Hydrocephalus;136
7.24.1;Epidemiology;136
7.24.2;Impact on Performance Skills;136
7.24.3;Impact on Client Factors (Body Functions and Structures);137
7.24.4;Precautions;137
7.24.5;Evaluation;137
7.24.6;Suggested Assessment Tools;137
7.24.7;FURTHER READING;138
7.25;Chapter 27: Cri Du Chat Syndrome;140
7.25.1;Epidemiology;140
7.25.2;Impact on Performance Skills;140
7.25.3;Impact on Client Factors (Body Functions and Structures);141
7.25.4;Precautions;141
7.25.5;Evaluation;141
7.25.6;Suggested Assessment Tools;141
7.25.7;FURTHER READING;142
7.26;Chapter 28: Cystic Fibrosis;144
7.26.1;Epidemiology;144
7.26.2;Impact on Performance Patterns;144
7.26.3;Impact on Performance Skills;144
7.26.4;Impact on Client Factors (Body Functions and Structures);144
7.26.5;Precautions;145
7.26.6;Evaluation;145
7.26.7;Suggested Assessment Tools;145
7.26.8;FURTHER READING;146
7.27;Chapter 29: Depression;148
7.27.1;Epidemiology;148
7.27.2;Impact on Performance Skills;148
7.27.3;Impact on Client Factors (Body Functions and Structures);149
7.27.4;Precautions;150
7.27.5;Evaluation;150
7.27.6;Suggested Assessment Tools;150
7.27.7;FURTHER READING;151
7.28;Chapter 30: Developmental Coordination Disorder;152
7.28.1;Epidemiology;152
7.28.2;Impact on Performance Skills;152
7.28.3;Impact on Client Factors (Body Functions and Structures);152
7.28.4;Precautions;152
7.28.5;Evaluation;153
7.28.6;Suggested Assessment Tools;153
7.28.7;FURTHER READING;154
7.29;Chapter 31: Disseminated Intravascular Coagulation;156
7.29.1;Epidemiology;156
7.29.2;Impact on Performance Skills;156
7.29.3;Impact on Client Factors (Body Functions and Structures);156
7.29.4;Precautions;157
7.29.5;Evaluation;157
7.29.6;Suggested Assessment Tools;157
7.29.7;FURTHER READING;157
7.30;Chapter 32: Down Syndrome (Trisomy 21);158
7.30.1;Epidemiology;158
7.30.2;Impact on Performance Skills;160
7.30.3;Impact on Client Factors (Body Functions and Structures);160
7.30.4;Precautions;160
7.30.5;Evaluation;161
7.30.6;Suggested Assessment Tools;161
7.30.7;FURTHER READING;162
7.31;Chapter 33: Dysrhythmias;164
7.31.1;Epidemiology;164
7.31.2;Impact on Performance Skills;164
7.31.3;Impact on Client Factors (Body Functions and Structures);164
7.31.4;Precautions;165
7.31.5;Evaluation;165
7.31.6;Suggested Assessment Tools;165
7.31.7;FURTHER READING;165
7.32;Chapter 34: Edwards’ Syndrome (Trisomy 18);166
7.32.1;Epidemiology;166
7.32.2;Impact on Performance Skills;167
7.32.3;Impact on Client Factors (Body Functions and Structures);168
7.32.4;Precautions;168
7.32.5;Evaluation;168
7.32.6;FURTHER READING;169
7.33;Chapter 35: Epilepsy (Seizure Disorder);170
7.33.1;Epidemiology;170
7.33.2;Impact on Performance Skills;170
7.33.3;Impact on Client Factors (Body Functions and Structures);171
7.33.4;Precautions;171
7.33.5;Evaluation;171
7.33.6;FURTHER READING;172
7.34;Chapter 36: Fetal Alcohol Syndrome Disorders;174
7.34.1;Epidemiology;174
7.34.2;Impact on Performance Skills;175
7.34.3;Impact on Client Factors (Body Functions and Structures);176
7.34.4;Precautions;176
7.34.5;Evaluation;176
7.34.6;Suggested Assessment Tools;176
7.34.7;FURTHER READING;177
7.35;Chapter 37: Fragile X Syndrome;178
7.35.1;Epidemiology;178
7.35.2;Impact on Performance Skills;178
7.35.3;Impact on Client Factors (Body Functions and Structures);179
7.35.4;Precautions;179
7.35.5;Evaluation;180
7.35.6;Suggested Assessment Tools;180
7.35.7;FURTHER READING;181
7.36;Chapter 38: Galactosemia;182
7.36.1;Epidemiology;182
7.36.2;Impact on Performance Skills;182
7.36.3;Impact on Client Factors (Body Functions and Structures);183
7.36.4;Precautions;183
7.36.5;Evaluation;184
7.36.6;Suggested Assessment Tools;184
7.36.7;FURTHER READING;185
7.37;Chapter 39: Gastroschisis;186
7.37.1;Epidemiology;186
7.37.2;Impact on Occupational Participation;186
7.37.3;Impact on Client Factors (Body Functions and Structures);186
7.37.4;Precautions;186
7.37.5;Evaluation;187
7.37.6;FURTHER READING;187
7.38;Chapter 40: Hemophilia;188
7.38.1;Epidemiology;188
7.38.2;Impact on Performance Skills;189
7.38.3;Impact on Client Factors (Body Functions and Structures);189
7.38.4;Precautions;189
7.38.5;Evaluation;189
7.38.6;Suggested Assessment Tools;189
7.38.7;FURTHER READING;191
7.39;Chapter 41: Hydrocephalus;192
7.39.1;Epidemiology;192
7.39.2;Impact on Performance Skills;192
7.39.3;Impact on Client Factors (Body Functions and Structures);194
7.39.4;Precautions;194
7.39.5;Evaluation;194
7.39.6;Suggested Assessment Tools;195
7.39.7;FURTHER READING;196
7.40;Chapter 42: Hyperbilirubinemia;198
7.40.1;Epidemiology;198
7.40.2;Impact on Client Factors (Body Functions and Structures);199
7.40.3;Precautions;199
7.40.4;Evaluation;199
7.40.5;FURTHER READING;199
7.41;Chapter 43: Hypoxic-Ischemic Encephalopathy;200
7.41.1;Epidemiology;200
7.41.2;Impact on Performance Skills;201
7.41.3;Impact on Client Factors (Body Functions and Structures);201
7.41.4;Precautions;201
7.41.5;Evaluation;201
7.41.6;Suggested Assessment Tools;201
7.41.7;FURTHER READING;201
7.42;Chapter 44: Intellectual Disabilities;204
7.42.1;Epidemiology;204
7.42.2;Impact on Performance Skills;204
7.42.3;Impact on Client Factors (Body Functions and Structures);205
7.42.4;Precautions;205
7.42.5;Evaluation;205
7.42.6;Suggested Assessment Tools;205
7.42.7;FURTHER READING;207
7.43;Chapter 45: Intraventricular Hemorrhage;208
7.43.1;Epidemiology;208
7.43.2;Impact on Performance Skills;209
7.43.3;Impact on Client Factors (Body Functions and Structures);209
7.43.4;Precautions;209
7.43.5;Evaluation;209
7.43.6;Suggested Assessment Tools;209
7.43.7;FURTHER READING;210
7.44;Chapter 46: Juvenile Diabetes;212
7.44.1;Epidemiology;212
7.44.2;Impact on Performance Patterns;213
7.44.3;Impact on Client Factors (Body Functions and Structures);213
7.44.4;Precautions;213
7.44.5;FURTHER READING;213
7.45;Chapter 47: Juvenile Rheumatoid Arthritis;214
7.45.1;Epidemiology;214
7.45.2;Impact on Performance Skills;214
7.45.3;Impact on Client Factors (Body Functions and Structures);215
7.45.4;Precautions;215
7.45.5;Evaluation;216
7.45.6;Suggested Assessment Tools;216
7.45.7;FURTHER READING;217
7.46;Chapter 48: Klinefelter’s Syndrome;218
7.46.1;Epidemiology;218
7.46.2;Impact on Performance Skills;218
7.46.3;Impact on Client Factors (Body Functions and Structures);218
7.46.4;Precautions;218
7.46.5;Evaluation;218
7.46.6;Suggested Assessment Tools;219
7.46.7;FURTHER READING;219
7.47;Chapter 49: Learning Disabilities;220
7.47.1;Epidemiology;220
7.47.2;Impact on Performance Skills;221
7.47.3;Impact on Client Factors (Body Functions and Structures);222
7.47.4;Precautions;222
7.47.5;Evaluation;223
7.47.6;Suggested Assessment Tools;223
7.47.7;FURTHER READING;224
7.48;Chapter 50: Legg-Calvé-Perthes Disease;226
7.48.1;Epidemiology;226
7.48.2;Impact on Performance Skills;226
7.48.3;Impact on Client Factors (Body Functions and Structures);226
7.48.4;Precautions;227
7.48.5;Evaluation;227
7.48.6;Suggested Assessment Tools;227
7.48.7;FURTHER READING;228
7.49;Chapter 51: Lesch-Nyhan Syndrome;230
7.49.1;Epidemiology;230
7.49.2;Impact on Performance Skills;230
7.49.3;Impact on Client Factors (Body Functions and Structures);231
7.49.4;Precautions;231
7.49.5;Evaluation;231
7.49.6;Suggested Assessment Tools;231
7.49.7;FURTHER READING;233
7.50;Chapter 52: Lordosis;234
7.50.1;Epidemiology;234
7.50.2;Impact on Performance Skills;234
7.50.3;Impact on Client Factors (Body Functions and Structures);234
7.50.4;Precautions;235
7.50.5;Evaluation;235
7.50.6;Suggested Assessment Tools;236
7.50.7;FURTHER READING;237
7.51;Chapter 53: Marfan Syndrome;238
7.51.1;Epidemiology;238
7.51.2;Impact on Performance Skills;238
7.51.3;Impact on Client Factors (Body Functions and Structures);239
7.51.4;Precautions;240
7.51.5;Evaluation;240
7.51.6;Suggested Assessment Tools;240
7.51.7;FURTHER READING;241
7.52;Chapter 54: Meconium Aspiration Syndrome;242
7.52.1;Epidemiology;242
7.52.2;Impact on Performance Skills;242
7.52.3;Impact on Client Factors;243
7.52.4;Precautions;243
7.52.5;Evaluation;244
7.52.6;Suggested Assessment Tools;244
7.52.7;FURTHER READING;245
7.53;Chapter 55: Micrognathia;246
7.53.1;Epidemiology;246
7.53.2;Impact on Performance Skills;246
7.53.3;Impact on Client Factors (Body Functions and Structures);246
7.53.4;Precautions;247
7.53.5;Evaluation;248
7.53.6;Suggested Assessment Tools;248
7.53.7;FURTHER READING;249
7.54;Chapter 56: Mononucleosis;250
7.54.1;Epidemiology;250
7.54.2;Impact on Performance Skills;250
7.54.3;Impact on Client Factors (Body Functions and Structures);251
7.54.4;Precautions;251
7.54.5;Evaluation;251
7.54.6;Suggested Assessment Tools;251
7.54.7;FURTHER READING;252
7.55;Chapter 57: Muscular Dystrophy;254
7.55.1;Epidemiology;254
7.55.2;Impact on Performance Skills;256
7.55.3;Impact on Client Factors (Body Functions and Structures);256
7.55.4;Precautions;257
7.55.5;Evaluation;257
7.55.6;Suggested Assessment Tools;257
7.55.7;FURTHER READING;258
7.56;Chapter 58: Necrotizing Enterocolitis;260
7.56.1;Epidemiology;260
7.56.2;Impact on Performance Skills;260
7.56.3;Impact on Client Factors (Body Functions and Structures);261
7.56.4;Precautions;261
7.56.5;Evaluation;262
7.56.6;Suggested Assessment Tools;262
7.56.7;FURTHER READING;263
7.57;Chapter 59: Neonatal Respiratory Distress Syndrome;264
7.57.1;Epidemiology;264
7.57.2;Impact on Performance Skills;264
7.57.3;Impact on Client Factors (Body Functions and Structures);265
7.57.4;Precautions;265
7.57.5;Evaluation;266
7.57.6;Suggested Assessment Tools;266
7.57.7;FURTHER READING;267
7.58;Chapter 60: Neurofibromatosis;268
7.58.1;Epidemiology;268
7.58.2;Impact on Performance Skills;268
7.58.3;Impact on Client Factors (Body Functions and Structures);269
7.58.4;Precautions;269
7.58.5;Evaluation;270
7.58.6;Suggested Assessment Tools;270
7.58.7;FURTHER READING;271
7.59;Chapter 61: Nystagmus;274
7.59.1;Epidemiology;274
7.59.2;Impact on Performance Skills;275
7.59.3;Impact on Client Factors (Body Functions and Structures);275
7.59.4;Precautions;275
7.59.5;Evaluation;276
7.59.6;Suggested Assessment Tools;276
7.59.7;FURTHER READING;277
7.60;Chapter 62: Obesity;278
7.60.1;Epidemiology;278
7.60.2;Impact on Performance Skills;278
7.60.3;Impact on Client Factors (Body Functions and Structures);278
7.60.4;Precautions;279
7.60.5;Evaluation;279
7.60.6;Suggested Assessment Tools;279
7.60.7;FURTHER READING;280
7.61;Chapter 63: Oppositional Defiant Disorder;282
7.61.1;Epidemiology;282
7.61.2;Impact on Performance Skills;282
7.61.3;Impact on Client Factors (Body Functions and Structures);283
7.61.4;Precautions;283
7.61.5;Evaluation;283
7.61.6;Suggested Assessment Tools;284
7.61.7;FURTHER READING;285
7.62;Chapter 64: Osteogenesis Imperfecta;286
7.62.1;Epidemiology;286
7.62.2;Impact on Performance Skills;286
7.62.3;Impact on Client Factors (Body Functions and Structures);286
7.62.4;Precautions;287
7.62.5;Evaluation;288
7.62.6;Suggested Assessment Tools;288
7.62.7;FURTHER READING;289
7.63;Chapter 65: Patau’s Syndrome (Trisomy 13);290
7.63.1;Epidemiology;290
7.63.2;Impact on Performance Skills;290
7.63.3;Impact on Client Factors (Body Functions and Structures);291
7.63.4;Precautions;292
7.63.5;Evaluation;293
7.63.6;Suggested Assessment Tools;293
7.63.7;FURTHER READING;294
7.64;Chapter 66: Periventricular Leukomalacia;296
7.64.1;Epidemiology;296
7.64.2;Impact on Performance Skills;296
7.64.3;Impact on Client Factors (Body Functions and Structures);297
7.64.4;Precautions;297
7.64.5;Evaluation;297
7.64.6;Suggested Assessment Tools;297
7.64.7;FURTHER READING;298
7.65;Chapter 67: Persistent Pulmonary Hypertension;300
7.65.1;Epidemiology;300
7.65.2;Impact on Performance Skills;300
7.65.3;Impact on Client Factors (Body Functions and Structures);301
7.65.4;Precautions;301
7.65.5;Evaluation;302
7.65.6;Suggested Assessment Tools;302
7.65.7;FURTHER READING;303
7.66;Chapter 68: Phenylketonuria;304
7.66.1;Epidemiology;304
7.66.2;Impact on Performance Skills;304
7.66.3;Impact on Client Factors (Body Functions and Structures);305
7.66.4;Precautions;305
7.66.5;Evaluation;305
7.66.6;Suggested Assessment Tools;305
7.66.7;FURTHER READING;306
7.67;Chapter 69: Pica;308
7.67.1;Epidemiology;308
7.67.2;Impact on Performance Skills;308
7.67.3;Impact on Client Factors (Body Functions and Structures);308
7.67.4;Precautions;309
7.67.5;Evaluation;309
7.67.6;Suggested Assessment Tools;309
7.67.7;FURTHER READING;310
7.68;Chapter 70: Posttraumatic Stress Disorder;312
7.68.1;Epidemiology;312
7.68.2;Impact on Performance Skills;312
7.68.3;Impact on Client Factors (Body Functions and Structures);313
7.68.4;Precautions;313
7.68.5;Evaluation;313
7.68.6;Suggested Assessment Tools;314
7.68.7;FURTHER READING;314
7.69;Chapter 71: Pneumonia;316
7.69.1;Epidemiology;316
7.69.2;Impact on Performance Skills;316
7.69.3;Impact on Client Factors (Body Functions and Structures);317
7.69.4;Precautions;317
7.69.5;Evaluation;318
7.69.6;Suggested Assessment Tools;318
7.69.7;FURTHER READING;318
7.70;Chapter 72: Prader-Willi Syndrome;320
7.70.1;Epidemiology;320
7.70.2;Impact on Performance Skills;320
7.70.3;Impact on Client Factors (Body Functions and Structures);322
7.70.4;Precautions;322
7.70.5;Impact on Client Factors (Body Functions and Structures);322
7.70.6;Evaluation;322
7.70.7;Suggested Assessment Tools;323
7.70.8;FURTHER READING;323
7.71;Chapter 73: Retinopathy of Prematurity;326
7.71.1;Epidemiology;326
7.71.2;Impact on Performance Skills;326
7.71.3;Impact on Client Factors (Body Functions and Structures);328
7.71.4;Precautions;328
7.71.5;Evaluation;328
7.71.6;Suggested Assessment Tools;328
7.71.7;FURTHER READING;329
7.72;Chapter 74: Rheumatic Heart Disease;330
7.72.1;Epidemiology;330
7.72.2;Impact on Performance Skills;330
7.72.3;Impact on Client Factors (Body Functions and Structures);331
7.72.4;Precautions;331
7.72.5;Evaluation;331
7.72.6;Suggested Assessment Tools;332
7.72.7;FURTHER READING;332
7.73;Chapter 75: Scoliosis;334
7.73.1;Epidemiology;334
7.73.2;Impact on Performance Skills;334
7.73.3;Impact on Client Factors (Body Functions and Structures);335
7.73.4;Precautions;336
7.73.5;Evaluation;337
7.73.6;Suggested Assessment Tools;337
7.73.7;FURTHER READING;338
7.74;Chapter 76: Separation Anxiety and Social Phobia;340
7.74.1;Epidemiology;340
7.74.2;Impact on Performance Skills;340
7.74.3;Impact on Client Factors (Body Functions and Structures);341
7.74.4;Precautions;341
7.74.5;Evaluation;341
7.74.6;Suggested Assessment Tools;342
7.74.7;FURTHER READING;342
7.75;Chapter 77: Sensory Processing Disorder;344
7.75.1;Epidemiology;344
7.75.2;Impact on Performance Skills;344
7.75.3;Impact on Client Factors (Body Functions and Structures);345
7.75.4;Precautions;345
7.75.5;Evaluation;346
7.75.6;Suggested Assessment Tools;346
7.75.7;FURTHER READING;347
7.76;Chapter 78: Sepsis;348
7.76.1;Epidemiology;348
7.76.2;Impact on Performance Skills;348
7.76.3;Impact on Client Factors (Body Functions and Structures);349
7.76.4;Precautions;349
7.76.5;Evaluation;349
7.76.6;Suggested Assessment Tools;349
7.76.7;FURTHER READING;350
7.77;Chapter 79: Sickle Cell Anemia;352
7.77.1;Epidemiology;352
7.77.2;Impact on Performance Skills;352
7.77.3;Impact on Client Factors (Body Functions and Structures);352
7.77.4;Precautions;354
7.77.5;Evaluation;354
7.77.6;Suggested Assessment Tools;354
7.77.7;FURTHER READING;355
7.78;Chapter 80: Spina Bifida;356
7.78.1;Epidemiology;356
7.78.2;Impact on Performance Skills;356
7.78.3;Impact on Client Factors (Body Functions and Structures);357
7.78.4;Precautions;357
7.78.5;Evaluation;358
7.78.6;Suggested Assessment Tools;358
7.78.7;FURTHER READING;359
7.79;Chapter 81: Spinal Muscular Atrophy;360
7.79.1;Epidemiology;360
7.79.2;Impact on Performance Skills;360
7.79.3;Impact on Client Factors (Body Functions and Structures);361
7.79.4;Precautions;361
7.79.5;Evaluation;361
7.79.6;Suggested Assessment Tools;361
7.79.7;FURTHER READING;363
7.80;Chapter 82: Strabismus;364
7.80.1;Epidemiology;364
7.80.2;Impact on Performance Skills;364
7.80.3;Impact on Client Factors (Body Functions and Structures);365
7.80.4;Precautions;365
7.80.5;Evaluation;365
7.80.6;Suggested Assessment Tools;365
7.80.7;FURTHER READING;366
7.81;Chapter 83: Tay-Sachs Disease;368
7.81.1;Epidemiology;368
7.81.2;Impact on Performance Skills;368
7.81.3;Impact on Client Factors (Body Functions and Structures);370
7.81.4;Precautions;370
7.81.5;Evaluation;370
7.81.6;Suggested Assessment Tools;370
7.81.7;FURTHER READING;371
7.82;Chapter 84: Tourette Syndrome;374
7.82.1;Epidemiology;374
7.82.2;Impact on Performance Skills;374
7.82.3;Impact on Client Factors (Body Functions and Structures);374
7.82.4;Precautions;375
7.82.5;Evaluation;375
7.82.6;Suggested Assessment Tools;375
7.82.7;FURTHER READING;376
8;Appendices;378
8.1;Appendice A: Websites for Research;380
8.2;Appendice B: Assessment Tools;384
8.2.1;Adolescent Role Assessment (ARA);384
8.2.2;Alberta Infant Motor Scale (AIMS);384
8.2.3;Árnadóttir OT-ADL Neurobehavioral Evaluation (A-ONE);384
8.2.4;Assessment of Communication and Interaction Skills (ACIS);384
8.2.5;Assessment of Ludic Behaviors (ALB);385
8.2.6;Assessment of Motor and Process Skills (AMPS);385
8.2.7;Balcones Sensory Integration Screening Kit;385
8.2.8;Bay Area Functional Performance Evaluation (BaFPE);385
8.2.9;Bayley Scale of Infant Development (BSID);385
8.2.10;Beery-Butenica Developmental Test of Visual-Motor Integration (VMI);385
8.2.11;Behavior Assessment Rating Scale (BASC);386
8.2.12;Behavioral Assessment of the Dysexecutive Syndrome (BADS);386
8.2.13;Benton Constructional Praxis Test;386
8.2.14;Box and Block Test;386
8.2.15;Bruininks-Oseretsky Test of Motor Performance (BOT-2);386
8.2.16;Canadian Occupational Performance Measure (COPM);387
8.2.17;Child and Adolescent Social Perception Measure;387
8.2.18;Child Behavior Checklist (CBCL);387
8.2.19;Child Behaviors Inventory of Playfulness (CBI);387
8.2.20;Child Occupational Self Assessment (COSA);387
8.2.21;Children’s Assessment of Participation and Enjoyment (CAPE);387
8.2.22;Children’s Handwriting Evaluation Scale (CHES);388
8.2.23;Children’s Paced Auditory Serial Addition Test (CHIPASAT);388
8.2.24;Choosing Outcomes and Accommodations for Children (COACH);388
8.2.25;Classroom Observation Guide;388
8.2.26;Computer System Usability Questionnaire;388
8.2.27;Coping Inventory;388
8.2.28;DeGangi-Berk Test of Sensory Integration (TSI);389
8.2.29;Denver Developmental Screening Test (DDST);389
8.2.30;Developmental Test of Visual Perception (DTVP);389
8.2.31;Dynamic Occupational Therapy Cognitive Assessment for Children (DOTCA-Ch);389
8.2.32;Early Coping Inventory;389
8.2.33;Erhardt Developmental Prehension Assessment (EDPA);389
8.2.34;Erhardt Developmental Vision Assessment, Revised (EDVA);390
8.2.35;Evaluation Tool of Children’s Handwriting (ETCH);390
8.2.36;Experience of Leisure Scale (TELS);390
8.2.37;Fine Motor Task Assessment;390
8.2.38;FirstSTEp Developmental Screening Test;390
8.2.39;Functional Independence Measure (WeeFIM);390
8.2.40;Gross Motor Function Measure (GMFM);390
8.2.41;Hawaii Early Learning Profi le (HELP);390
8.2.42;Home Observation and Measurement of the Environment (HOME);391
8.2.43;Infant/Toddler Sensory Profi le;391
8.2.44;Interest Checklist;391
8.2.45;Klein-Bell Activities of Daily Living Scale;391
8.2.46;Knox Cube Test;391
8.2.47;Knox Preschool Play Scale;391
8.2.48;Leisure Boredom Scale (LBS);391
8.2.49;Leisure Competence Measure;392
8.2.50;Leisure Diagnostic Battery;392
8.2.51;Leisure Satisfaction Scale;392
8.2.52;Lincoln-Oseretsky Motor Development Scale;392
8.2.53;Lowenstein Occupational Therapy Cognitive Assessment (LOTCA);392
8.2.54;Mayo-Portland Adaptability Inventory (MPAI);392
8.2.55;McCarthy Scale of Children’s Abilities;392
8.2.56;Miller Assessment for Preschoolers (MAP);393
8.2.57;Miller Function and Participation Scales (M-FUN-S);393
8.2.58;Model of Human Occupation Screening Tool (MOHOST);393
8.2.59;Mother-Child Interaction Checklist;393
8.2.60;Motor Assessment Battery for Children (Movement ABC);393
8.2.61;Movement Assessment for Infants (MAI);393
8.2.62;NIH Activity Record;394
8.2.63;Nowicki-Strickland Locus of Control Scale for Children (TIM [ C ] );394
8.2.64;Occupational Circumstances Assessment Interview and Rating Scale (OCAIRS);394
8.2.65;Occupational Performance History Interview (OPHI);394
8.2.66;Peabody Developmental Motor Scales 2 (PDMS-2);394
8.2.67;Pediatric Activity Card Sort (PACS);394
8.2.68;Pediatric Evaluation of Disability Inventory (PEDI);395
8.2.69;Pediatric Interest Profile (PIP);395
8.2.70;Pediatric Volitional Questionnaire (PVQ);395
8.2.71;Perceived Efficacy and Goal Setting System (PEGS);395
8.2.72;Preferences for Activities for Children (PACS);395
8.2.73;Preschool and Kindergarten Behavior Scales (PKBS);396
8.2.74;School Assessment of Motor and Process Skills (School AMPS);396
8.2.75;School Function Assessment (SFA);396
8.2.76;School Sensory Profile;396
8.2.77;School Setting Interview (SSI);396
8.2.78;Self-Assessment of Occupational Functioning (SAOF);396
8.2.79;Sensory Processing Measure (SPM);397
8.2.80;Sensory Profile;397
8.2.81;Short Child Occupational Profile (SCOPE);397
8.2.82;Social Skills Rating System;397
8.2.83;Test of Environmental Supportiveness;397
8.2.84;Test of Everyday Attention for Children (TEA-Ch);397
8.2.85;Test of Visual-Motor Skills: Upper Level (TVMS:UL);398
8.2.86;Test of Visual-Perceptual Skills (TVPS-3);398
8.2.87;Test of Visual-Perceptual Skills: Upper Level (Nonmotor) (TVPS:UL);398
8.2.88;Toddler and Infant Motor Evaluation (TIME);398
8.2.89;Vineland Adaptive Behavior Scale (VABS);398
9;Index;400

Ihre Fragen, Wünsche oder Anmerkungen
Vorname*
Nachname*
Ihre E-Mail-Adresse*
Kundennr.
Ihre Nachricht*
Lediglich mit * gekennzeichnete Felder sind Pflichtfelder.
Wenn Sie die im Kontaktformular eingegebenen Daten durch Klick auf den nachfolgenden Button übersenden, erklären Sie sich damit einverstanden, dass wir Ihr Angaben für die Beantwortung Ihrer Anfrage verwenden. Selbstverständlich werden Ihre Daten vertraulich behandelt und nicht an Dritte weitergegeben. Sie können der Verwendung Ihrer Daten jederzeit widersprechen. Das Datenhandling bei Sack Fachmedien erklären wir Ihnen in unserer Datenschutzerklärung.